These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

546 related items for PubMed ID: 17351431

  • 1. Potential of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging.
    Tsuda N, Okada M, Murakami T.
    Invest Radiol; 2007 Apr; 42(4):242-7. PubMed ID: 17351431
    [Abstract] [Full Text] [Related]

  • 2. New proposal for the staging of nonalcoholic steatohepatitis: evaluation of liver fibrosis on Gd-EOB-DTPA-enhanced MRI.
    Tsuda N, Okada M, Murakami T.
    Eur J Radiol; 2010 Jan; 73(1):137-42. PubMed ID: 19026502
    [Abstract] [Full Text] [Related]

  • 3. Potential for differential diagnosis with gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in experimental hepatic tumors.
    Tsuda N, Kato N, Murayama C, Narazaki M, Yokawa T.
    Invest Radiol; 2004 Feb; 39(2):80-8. PubMed ID: 14734922
    [Abstract] [Full Text] [Related]

  • 4. The Possibility of differentiation between nonalcoholic steatohepatitis and fatty liver in rabbits on Gd-EOB-DTPA-enhanced open-type MRI scans.
    Sonoda A, Nitta N, Ohta S, Nitta-Seko A, Tsuchiya K, Nagatani Y, Mukaisho K, Takahashi M, Murata K.
    Acad Radiol; 2011 Apr; 18(4):525-9. PubMed ID: 21237679
    [Abstract] [Full Text] [Related]

  • 5. Gd-EOB-DTPA-enhanced-MR imaging in the inflammation stage of nonalcoholic steatohepatitis (NASH) in mice.
    Yamada T, Obata A, Kashiwagi Y, Rokugawa T, Matsushima S, Hamada T, Watabe H, Abe K.
    Magn Reson Imaging; 2016 Jul; 34(6):724-729. PubMed ID: 26979540
    [Abstract] [Full Text] [Related]

  • 6. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA.
    Tamada T, Ito K, Sone T, Yamamoto A, Yoshida K, Kakuba K, Tanimoto D, Higashi H, Yamashita T.
    J Magn Reson Imaging; 2009 Mar; 29(3):636-40. PubMed ID: 19243060
    [Abstract] [Full Text] [Related]

  • 7. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
    Clément O, Mühler A, Vexler V, Berthezène Y, Brasch RC.
    Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
    [Abstract] [Full Text] [Related]

  • 8. Assessment of liver function in thioacetamide-induced rat acute liver injury using an empirical mathematical model and dynamic contrast-enhanced MRI with Gd-EOB-DTPA.
    Saito S, Moriyama Y, Kobayashi S, Ogihara R, Koto D, Kitamura A, Matsushita T, Nishiura M, Murase K.
    J Magn Reson Imaging; 2012 Dec; 36(6):1483-9. PubMed ID: 22711439
    [Abstract] [Full Text] [Related]

  • 9. [Renal enhancement and excretion of the hepatobiliary contrast agent Gd-EOB-DTPA].
    Zangos S, Hammerstingl R, Mack MG, Straub R, Engelmann K, Eichler K, Balzer T, Vogl TJ.
    Rofo; 2001 Nov; 173(11):1034-40. PubMed ID: 11704914
    [Abstract] [Full Text] [Related]

  • 10. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
    Dahlström N, Persson A, Albiin N, Smedby O, Brismar TB.
    Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
    [Abstract] [Full Text] [Related]

  • 11. Phantom and animal studies of a new hepatobiliary agent for MR imaging: comparison of Gd-DTPA-DeA with Gd-EOB-DTPA.
    Yoshikawa K, Inoue Y, Akahane M, Shimada M, Itoh S, Seno A, Hayashi S.
    J Magn Reson Imaging; 2003 Aug; 18(2):204-9. PubMed ID: 12884333
    [Abstract] [Full Text] [Related]

  • 12. Usefulness of Gd-EOB-DTPA-enhanced MR imaging in the evaluation of simple steatosis and nonalcoholic steatohepatitis.
    Wu Z, Matsui O, Kitao A, Kozaka K, Koda W, Kobayashi S, Ryu Y, Minami T, Sanada J, Gabata T.
    J Magn Reson Imaging; 2013 May; 37(5):1137-43. PubMed ID: 23172731
    [Abstract] [Full Text] [Related]

  • 13. Liver vessel enhancement by Gd-BOPTA and Gd-EOB-DTPA: a comparison in healthy volunteers.
    Brismar TB, Dahlstrom N, Edsborg N, Persson A, Smedby O, Albiin N.
    Acta Radiol; 2009 Sep; 50(7):709-15. PubMed ID: 19701821
    [Abstract] [Full Text] [Related]

  • 14. Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents.
    Husarik DB, Gupta RT, Ringe KI, Boll DT, Merkle EM.
    Acad Radiol; 2011 Dec; 18(12):1549-54. PubMed ID: 21958599
    [Abstract] [Full Text] [Related]

  • 15. Dilution method of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI).
    Motosugi U, Ichikawa T, Sou H, Sano K, Ichikawa S, Tominaga L, Araki T.
    J Magn Reson Imaging; 2009 Oct; 30(4):849-54. PubMed ID: 19787734
    [Abstract] [Full Text] [Related]

  • 16. A simple and inexpensive system for controlling body temperature in small animal experiments using MRI and the effect of body temperature on the hepatic kinetics of Gd-EOB-DTPA.
    Murase K, Assanai P, Takata H, Saito S, Nishiura M.
    Magn Reson Imaging; 2013 Dec; 31(10):1744-51. PubMed ID: 24094686
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of gadoxetate disodium as a contrast agent for mouse liver imaging: comparison with gadobenate dimeglumine.
    Kiryu S, Inoue Y, Watanabe M, Izawa K, Shimada M, Tojo A, Yoshikawa K, Ohtomo K.
    Magn Reson Imaging; 2009 Jan; 27(1):101-7. PubMed ID: 18599243
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of hepatic function using dynamic contrast-enhanced magnetic resonance imaging in melanocortin 4 receptor-deficient mice as a model of nonalcoholic steatohepatitis.
    Yamada T, Kashiwagi Y, Rokugawa T, Kato H, Konishi H, Hamada T, Nagai R, Masago Y, Itoh M, Suganami T, Ogawa Y, Abe K.
    Magn Reson Imaging; 2019 Apr; 57():210-217. PubMed ID: 30465867
    [Abstract] [Full Text] [Related]

  • 19. T2-weighted magnetic resonance imaging of the liver: evaluation of the effect in signal intensity after Gd-EOB-DTPA enhancement.
    Tamada T, Ito K, Yoshida K, Sone T, Murakami K, Kanki A, Watanabe S, Higashi H, Yamashita T.
    J Comput Assist Tomogr; 2010 Apr; 34(2):182-6. PubMed ID: 20351500
    [Abstract] [Full Text] [Related]

  • 20. Gd-EOB-DTPA-enhanced magnetic resonance imaging findings of nondiffuse fatty change of the liver.
    Yamamoto A, Tamada T, Sone T, Higashi H, Yamashita T, Ito K.
    J Comput Assist Tomogr; 2010 Apr; 34(6):868-73. PubMed ID: 21084902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.